Athens, Greece

Alexios Leandros Skaltsounis

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Alexios Leandros Skaltsounis

Introduction

Alexios Leandros Skaltsounis is a notable inventor based in Athens, Greece. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of two patents, Skaltsounis is recognized for his work in developing novel therapeutic methods.

Latest Patents

Skaltsounis's latest patents include compositions and methods for treating cancer using 5-bromo-indirubins and thioindirubins. The first patent focuses on 5-Br-indirubin derivatives, which have shown potential in cancer treatment. The second patent involves thioindirubin derivatives, further expanding the possibilities for effective cancer therapies.

Career Highlights

Throughout his career, Skaltsounis has worked with esteemed institutions such as City of Hope and the National and Kapodistrian University of Athens. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Sangkil Nam and David A. Horne. Their collaborative efforts have played a crucial role in advancing the research and development of cancer treatment methods.

Conclusion

Alexios Leandros Skaltsounis is a prominent figure in the field of cancer research, with innovative patents that hold promise for future therapies. His contributions continue to impact the scientific community and offer hope for improved cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…